343 related articles for article (PubMed ID: 1650835)
61. Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons.
Jewett DC; Mosberg HI; Woods JH
Psychopharmacology (Berl); 1996 Oct; 127(3):225-30. PubMed ID: 8912400
[TBL] [Abstract][Full Text] [Related]
62. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
Cao YJ; Bian JT; Bhargava HN
Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
[TBL] [Abstract][Full Text] [Related]
63. Up-regulation of brain N-methyl-D-aspartate receptors following multiple intracerebroventricular injections of [D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin II in mice.
Bhargava HN; Kumar S; Bian JT
Peptides; 1997; 18(10):1609-13. PubMed ID: 9437723
[TBL] [Abstract][Full Text] [Related]
64. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
[TBL] [Abstract][Full Text] [Related]
65. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
[TBL] [Abstract][Full Text] [Related]
66. Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin.
Heyman JS; Vaught JL; Mosberg HI; Haaseth RC; Porreca F
Eur J Pharmacol; 1989 Jun; 165(1):1-10. PubMed ID: 2548877
[TBL] [Abstract][Full Text] [Related]
67. Effects of some 7-arylidene and 7-heteroarylidene morphinan-6-ones on the antinociceptive activity of [D-Pen2, D-Pen5]enkephalin and [D-Ala2, Glu4]deltorphin II and on multiple opioid receptors.
Bhargava HN; Zhao GM; Bian JT; Nan Y; Upadhyaya SP; Xu W; Dunn WJ; Bauer L
Peptides; 1997; 18(5):695-701. PubMed ID: 9213363
[TBL] [Abstract][Full Text] [Related]
68. Gx/z is regulated by mu but not delta opioid receptors in the stimulation of the low Km GTPase activity in mouse periaqueductal grey matter.
Garzón J; Martínez-Peña Y; Sanchez-Blázquez P
Eur J Neurosci; 1997 Jun; 9(6):1194-200. PubMed ID: 9215703
[TBL] [Abstract][Full Text] [Related]
69. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat.
Ossipov MH; Kovelowski CJ; Nichols ML; Hruby VJ; Porreca F
Pain; 1995 Sep; 62(3):287-293. PubMed ID: 8657428
[TBL] [Abstract][Full Text] [Related]
70. Preliminary ligand binding data for subtypes of the delta opioid receptor in rat brain membranes.
Xu H; Ni Q; Jacobson AE; Rice KC; Rothman RB
Life Sci; 1991; 49(18):PL141-6. PubMed ID: 1681403
[TBL] [Abstract][Full Text] [Related]
71. Streptozotocin-induced diabetes selectively enhances antinociception mediated by delta 1- but not delta 2-opioid receptors.
Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
Life Sci; 1994; 55(6):PL121-6. PubMed ID: 8035657
[TBL] [Abstract][Full Text] [Related]
72. Activation of mu- and delta-opioid receptors present on the same nerve terminals depresses transmitter release in the mouse hypogastric ganglion.
Rogers H; Henderson G
Br J Pharmacol; 1990 Nov; 101(3):505-12. PubMed ID: 1981687
[TBL] [Abstract][Full Text] [Related]
73. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
Miaskowski C; Levine JD
Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
[TBL] [Abstract][Full Text] [Related]
74. Involvement of dopamine-dependent and -independent mechanisms in the rewarding effects mediated by delta opioid receptor subtypes in mice.
Suzuki T; Tsuji M; Mori T; Ikeda H; Misawa M; Nagase H
Brain Res; 1997 Jan; 744(2):327-34. PubMed ID: 9027392
[TBL] [Abstract][Full Text] [Related]
75. Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1994 Feb; 268(2):701-8. PubMed ID: 8113981
[TBL] [Abstract][Full Text] [Related]
76. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
[TBL] [Abstract][Full Text] [Related]
77. Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro.
Kramer TH; Toth G; Haaseth RC; Matsunaga TO; Davis P; Hruby VJ; Burks TF
Life Sci; 1991; 48(9):881-6. PubMed ID: 1847736
[TBL] [Abstract][Full Text] [Related]
78. Role of opioid receptors (mu, delta 1, delta 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat.
Wang XM; Yan JQ; Zhang KM; Mokha SS
Brain Res; 1996 Nov; 739(1-2):235-43. PubMed ID: 8955943
[TBL] [Abstract][Full Text] [Related]
79. Effects of competitive and noncompetitive antagonists of the N-methyl-D-aspartate receptor on the analgesic action of delta 1- and delta 2-opioid receptor agonists in mice.
Bharagava HN; Zhao GM
Br J Pharmacol; 1996 Dec; 119(8):1586-90. PubMed ID: 8982505
[TBL] [Abstract][Full Text] [Related]
80. DAMGO ([D-Ala2,NMePhe4,Gly-ol]enkephalin), but not DPLPE ([D-Pen2,L- Pen5]enkephalin), specifically inhibits methamphetamine-induced behavioral responses in the mouse.
Ukai M; Toyoshi T; Kameyama T
Neuropharmacology; 1993 Oct; 32(10):1019-24. PubMed ID: 8295712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
